Literature DB >> 32472479

HLA-B*51 allelic and carrier frequency in Kazakhstan: insights into Behçet's disease prevalence in Central Asia.

Dimitri Poddighe1, Aida Turganbekova2, Zaure Mukusheva3, Altynay Abdirakhmanova4, Maikesh Assylbekova3, Saniya Abdrakhmanova2.   

Abstract

Behçet's disease (BD) is a systemic vasculitis whose prevalence varies according to the ethnicity. HLA-B*51 is a well-known genetic factor predisposing to BD: populations with higher HLA-B*51 allelic frequencies are also those with a greater disease prevalence, as occurs in the Silk Road countries. However, the BD prevalence is unknown in many countries, including Kazakhstan and, in general, Central Asia, despite the location on or near the Silk Road. Due to the lack of clinical studies from this area, we analyzed the bone marrow donors registry in Kazakhstan, in order to assess the HLA-B*51 allelic and carrier frequencies, which resulted to be 8.14 and 15.28%, respectively. Through a comparison with the same parameters in other countries (by performing a data search in the medical literature and in the Allele Frequency Net Database), we might speculate a BD prevalence in Kazakhstan of 10-15/100.000 at least. This result should prompt a greater clinical consideration of this disease in Central Asia, as well as the publication of clinical data from this geographic area.

Entities:  

Keywords:  Allelic frequency; Behçet’s disease; Central Asia; HLA-B*57; Kazakhstan; Prevalence

Year:  2020        PMID: 32472479     DOI: 10.1007/s11739-020-02369-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  4 in total

1.  Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease.

Authors:  C Salvarani; L Boiardi; V Mantovani; I Olivieri; G Ciancio; F Cantini; F Salvi; R Malatesta; C Molinotti; M Govoni; F Trotta; D Filippini; G Paolazzi; M Viggiani
Journal:  J Rheumatol       Date:  2001-08       Impact factor: 4.666

2.  Genetics of Behçet's disease in Sardinia: two distinct extended HLA haplotypes harbour the B*51 allele in the normal population and in patients.

Authors:  M Piga; F Paladini; S Lai; G Erre; G Passiu; C Carcassi; R Sorrentino; A Mathieu
Journal:  Clin Exp Rheumatol       Date:  2012-09-28       Impact factor: 4.473

3.  Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51.

Authors:  N Mizuki; H Inoko; N Mizuki; H Tanaka; J Kera; K Tsuiji; S Ohno
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-11       Impact factor: 4.799

4.  [Behçet disease in children in France].

Authors:  I Kone-Paut; J L Bernard
Journal:  Arch Fr Pediatr       Date:  1993 Aug-Sep
  4 in total
  2 in total

1.  Performance of diagnostic criteria in pediatric Behçet's disease.

Authors:  Tuba Kurt; Fatma Aydın; Müge Sezer; P Nilüfer Tekgöz; Zahide Ekici Tekin; Elif Çelikel; Cüneyt Karagöl; Serkan Coşkun; Banu Acar
Journal:  Rheumatol Int       Date:  2021-01-15       Impact factor: 2.631

2.  HLA major allele group frequencies in a diverse population of the Free State Province, South Africa.

Authors:  Walter J Janse van Rensburg; André de Kock; Chené Bester; Jean F Kloppers
Journal:  Heliyon       Date:  2021-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.